Vetoquinol - Universal Registration Document - 2021

2 Vetoquinol Universal Registration Document 2020 Financial report 45 STATEMENT OF NON-FINANCIAL PERFORMANCE Carbon footprint 2.5 Carbon footprint The Group presents its environmental footprint for its four most significant direct environmental aspects: waste, drinking water consumption, energy consumption (gas and liquid) and carbon emissions. The highest-contributing sites and activities are taken into account in the calculation of the indicators. All pro- duction plants and R&D sites are considered with regard to the four environmental aspects. The main sales ope- rations, with a sales force of at least 20 employees, are now taken into account in liquid energy 2.5.1 Prevention of pollution Given that it is a pharmaceutical company mainly engaged in formulation, Vetoquinol produces no active chemical ingredients and the only direct atmospheric emissions generated by its production plants are com- bustion products emanating from the gas boilers. All potential particle emissions generated by the develop- ment laboratories are filtered. There is no soil pollution. All production plants have waterproof floors designed to contain any accidental spillage. Outside storage units are situated inside reten- tion basins. Regarding water pollution, the Canadian and Polish sites have sewer systems connected to the local municipal wastewater treatment plant. The Italian and Brazilian sites do not produce any wastewater (excluding sanitary wastewater). All the wastewater they generate during production processes is destroyed as waste by a specia- list company. At Magny-Vernois, the effluents generated by production facilities are sent to an on-site biological treatment plant used to eliminate biodegradable pollutants. It is sup- ported by a perozonation facility (combining the treatment of oxygenated and ozone water) in order to eliminate non-biodegradable mole- cules. The wastewater treatment process at this site is an innovation in the French pharmaceutical industry. It also received an innovation grant from the Rhone Medi- terranean Corsica water agency. This investment, made in 2015, is testament to Veto- quinol’s foresight given that no current regulation requires the treatment of medical waste in aqueous effluents. 2.4.8 Working hours In each of its subsidiaries, Vetoquinol complies with sta- tutory and contractual requirements regarding working hours. Work time organization varies across the Group depen- ding on local conditions applicable to each subsidiary and operation. Part-time work represents 2.1% for the Group as a whole. This percentage is slightly lower than in 2019 (2.3%) mainly due to a decrease in part-time work in Europe (France and Germany). Employees switching to part-time employment have generally chosen this arran- gement themselves. Group policy is generally to hire permanent employees. As a result, the proportion of temporary employees is very low. Type of Contract Americas Asia Europe Total Fixed-term 2.6% 1.2% 6.3% 4.3% Permanent 97.4% 98.8% 93.7% 95.7% TOTAL HEADCOUNT 100.0% 100.0% 100.0% 100.0%